Glial fibrillary acidic protein in Guillain-Barré syndrome: Methodological issues

Authors

  • A. Petzold,

    1. Dept. of Neuroimmunology, Institute of Neurology, Queen Square, London WC1N 3BG, UK
    Search for more papers by this author
  • L. Rosengren,

    1. Institute of Clinical Neuroscience, Department of Neurology, Sahlgrens University Hospital, University of Goteborg, Sweden
    Search for more papers by this author
  • M.M. Verbeek,

    1. Radboud University Nijmegen Medical Centre, Donders Centre for Brain, Cognition and Behaviour, Department of Neurology, Laboratory of Pediatrics and Neurology, Nijmegen, The Netherlands
    Search for more papers by this author
  • Francesca Notturno MD,

    1. Department of Human Motor Sciences and Neuromuscular Diseases Unit, University “G. d'Annunzio” and Institute of Aging, Foundation University “G. d'Annunzio,” Clinica Neurologica, Ospedale “SS. Annunziata,” Chieti, Italy
    Search for more papers by this author
  • Christina M. Caporale MD,

    1. Department of Human Motor Sciences and Neuromuscular Diseases Unit, University “G. d'Annunzio” and Institute of Aging, Foundation University “G. d'Annunzio,” Clinica Neurologica, Ospedale “SS. Annunziata,” Chieti, Italy
    Search for more papers by this author
  • Angelo DeLauretis MD,

    1. Respiratory Disease Department, Catholic University, Rome, Italy
    Search for more papers by this author
  • Antonino Uncini MD

    1. Department of Human Motor Sciences and Neuromuscular Diseases Unit, University “G. d'Annunzio” and Institute of Aging, Foundation University “G. d'Annunzio,” Clinica Neurologica, Ospedale “SS. Annunziata,” Chieti, Italy
    Search for more papers by this author

No abstract is available for this article.

Ancillary